×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
PMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q1 2024
MSN
PMN stock results show that ProMIS Neurosciences beat analyst estimates for earnings per share the first quarter of 2024.
9 hours ago
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
GlobeNewswire
CAMBRIDGE, Massachusetts and TORONTO, Ontario, May 14, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage...
1 day ago
Is ProMIS Neurosciences Inc's (TSE:PMN) CEO Paid At A Competitive Rate?
Yahoo Movies Canada
Elliot Goldstein has been the CEO of ProMIS Neurosciences Inc (TSE:PMN) since 2015. This report will, first, examine the CEO compensation levels in...
6 days ago
PMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q1 2024
MSN
ProMIS Neurosciences (NASDAQ:PMN) just reported results for the first quarter of 2024. ProMIS Neurosciences reported earnings per share of...
13 hours ago
ProMIS doses first subject in study of Alzheimer's therapy
Clinical Trials Arena
ProMIS Neurosciences has dosed the first subjects in a Phase Ia clinical trial of PMN310 as a potential Alzheimer's disease (AD) treatment.
5 months ago
ProMIS moving potential Parkinson's vaccine into animal studies
Parkinson's News Today
ProMIS Neurosciences announced arriving at a lead candidate vaccine against the misfolded alpha-synuclein protein, which the company plans...
3 months ago
Critical Contrast: ProMIS Neurosciences (NASDAQ:PMN) vs. Bullfrog AI (NASDAQ:BFRG)
Defense World
Read Critical Contrast: ProMIS Neurosciences (NASDAQ:PMN) vs. Bullfrog AI (NASDAQ:BFRG) at Defense World.
1 week ago
PMN Stock Quote Price and Forecast
CNN
ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of...
4 months ago
ProMIS Neurosciences publishes study highlighting oligomers in journal bioRxiv - TipRanks.com
Tipranks
ProMIS Neurosciences announced the publication of a paper titled, “Relationship between therapeutic activity and preferential targeting of...
2 weeks ago
Companies To Watch KeifeRx
Life Science Leader
Founded in late 2019, KeifeRx is repurposing oncology drugs for neurodegenerative disorders.
4 months ago